(Q35855891)

10 August 2017

1 reference

title

Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy (English)

1 reference

cost-effectiveness analysis

10 August 2017

0 references

1 reference

1 reference

Hilmar Burchardi

1

1 reference

10 August 2017

Heinz Schneider

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

12

1 reference

10 August 2017

page(s)

793-813

1 reference

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

10 August 2017

cites work

1 reference

12 December 2020

Patterns of resource consumption in medical intensive care

1 reference

12 December 2020

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

12 December 2020

Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations

1 reference

12 December 2020

Ventilator-induced injury: from barotrauma to biotrauma.

1 reference

12 December 2020

Economic burden of illness imposed by severe sepsis in Austria

1 reference

12 December 2020

Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care.

1 reference

12 December 2020

The economics and cost-effectiveness of critical care medicine

1 reference

12 December 2020

A new concept for DRG-based reimbursement of services in German intensive care units: results of a pilot study

1 reference

12 December 2020

Guidelines for the management of severe sepsis and septic shock. The International Sepsis Forum

1 reference

12 December 2020

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

1 reference

12 December 2020

Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome

1 reference

12 December 2020

Impact of standard procedures and clinical standards on cost-effectiveness and intensive care unit performance in adult patients after cardiac surgery

1 reference

12 December 2020

Treating patients with severe sepsis

1 reference

12 December 2020

Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality

1 reference

12 December 2020

Pathophysiology and treatment of septic shock

1 reference

12 December 2020

Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).

1 reference

12 December 2020

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

1 reference

12 December 2020

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

12 December 2020

Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997.

1 reference

12 December 2020

Clinical trials of mediator-directed therapy in sepsis: what have we learned?

1 reference

12 December 2020

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

1 reference

12 December 2020

Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement

1 reference

12 December 2020

Lowering hospital charges in the trauma intensive care unit while maintaining quality of care by increasing resident and attending physician awareness

1 reference

12 December 2020

Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine

1 reference

12 December 2020

Economic analysis of the intensive care unit: a dilemma.

1 reference

12 December 2020

Source control in the management of sepsis

1 reference

12 December 2020

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

12 December 2020

Sepsis syndromes: understanding the role of innate and acquired immunity.

1 reference

12 December 2020

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

1 reference

12 December 2020

Assessing the efficiency of the admission process to a critical care unit: does the literature allow the use of benchmarking?

1 reference

12 December 2020

A method for assessing the clinical performance and cost-effectiveness of intensive care units: a multicenter inception cohort study

1 reference

12 December 2020

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

1 reference

12 December 2020

The epidemiology of severe sepsis in children in the United States.

1 reference

12 December 2020

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators

1 reference

12 December 2020

High-volume haemofiltration in human septic shock

1 reference

12 December 2020

A review of cost studies of intensive care units: problems with the cost concept

1 reference

12 December 2020

Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late

1 reference

12 December 2020

Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine

1 reference

12 December 2020

The cost of intensive care: a comparison on one unit between 1988 and 1991.

1 reference

12 December 2020

ICU and non-ICU cost per day

1 reference

12 December 2020

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

1 reference

12 December 2020

Patient characteristics and costs of severe sepsis and septic shock in Quebec

1 reference

12 December 2020

A new method of accurately identifying costs of individual patients in intensive care: the initial results

1 reference

12 December 2020

Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?

1 reference

12 December 2020

Cost comparison of antibacterial therapies for serious infections. A New Zealand 3-hospital study

1 reference

12 December 2020

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

1 reference

12 December 2020

The development of a method for comparative costing of individual intensive care units. The Intensive Care Working Group on Costing.

1 reference

12 December 2020

Consequences of discharges from intensive care at night

1 reference

12 December 2020

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

12 December 2020

[Quality management and individual performance recording in intensive care using the Goettingen Information System for Intensive Care and Surgery (GISI)]

1 reference

12 December 2020

Reducing mortality in sepsis: new directions

1 reference

12 December 2020

Assessing the effectiveness of critical pathways on reducing resource utilization in the surgical intensive care unit

1 reference

12 December 2020

Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial

1 reference

12 December 2020

Relationship between TISS and ICU cost.

1 reference

12 December 2020

Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia--Chicago, Illinois, May 2002.

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Costing intensive care services: a review of study methods, results and limitations

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Should continuous renal replacement therapy be used for 'non-renal' indications in critically ill patients with shock?

1 reference

12 December 2020

The relation between TISS and real paediatric ICU costs: a case study with generalizable methodology

1 reference

12 December 2020

Mechanical ventilation-induced pulmonary edema. Interaction with previous lung alterations.

1 reference

12 December 2020

Cost accounting of adult intensive care: methods and human and capital inputs

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Cost reduction and outcome improvement in the intensive care unit.

1 reference

12 December 2020

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group

1 reference

12 December 2020

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia

1 reference

12 December 2020

A systematic review of the cost-effectiveness of noncardiac transitional care units

1 reference

12 December 2020

[Cost analysis and outcome prediction with the Therapeutic Intervention Scoring System (TISS and TISS-28]

1 reference

12 December 2020

Sepsis and septic shock

1 reference

12 December 2020

Critical care delivery in the intensive care unit: defining clinical roles and the best practice model

1 reference

12 December 2020

The pathophysiology and treatment of sepsis

1 reference

12 December 2020

Continuous hemofiltration as blood purification in sepsis.

1 reference

12 December 2020

Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.

1 reference

12 December 2020

Analysis of costs in a pediatric ICU

1 reference

12 December 2020

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

1 reference

12 December 2020

Intensive insulin therapy in critically ill patients

1 reference

12 December 2020

Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?

1 reference

12 December 2020

A cost-effectiveness analysis of stays in intensive care units

1 reference

12 December 2020

1 reference

12 December 2020

Effects of a medical intensivist on patient care in a community teaching hospital

1 reference

12 December 2020

Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

Supportive therapy of the sepsis syndrome

1 reference

12 December 2020

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

1 reference

12 December 2020

An economic evaluation of activated protein C treatment for severe sepsis

1 reference

12 December 2020

Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study

1 reference

12 December 2020

Steroid controversy in sepsis and septic shock: a meta-analysis

1 reference

12 December 2020

Quality, cost, and outcome of intensive care in a public hospital in Bombay, India

1 reference

12 December 2020

Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use

1 reference

12 December 2020

Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections

1 reference

12 December 2020

Cost of intensive care in a Norwegian University hospital 1997-1999

1 reference

12 December 2020

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

12 December 2020

Twenty-four hour presence of physicians in the ICU

1 reference

12 December 2020

Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care

1 reference

12 December 2020

Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation.

1 reference

12 December 2020

Epidemiology of sepsis syndrome in 8 academic medical centers

1 reference

12 December 2020

The sepsis syndrome. Definition and general approach to management

1 reference

12 December 2020

The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991-1998. Application of Medicare claims data

1 reference

12 December 2020

Effects of an organized critical care service on outcomes and resource utilization: a cohort study

1 reference

12 December 2020

Burden of illness imposed by severe sepsis in Germany.

1 reference

12 December 2020

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

1 reference

12 December 2020

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients

1 reference

12 December 2020

10.2165/00019053-200422120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1009292170

0 references

1 reference